BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 3313677)

  • 41. Comparison of sucralfate and ranitidine twice daily in duodenal ulcer treatment: a multicenter randomized double-blind study.
    Archimandritis A; Charitopoulos N; Diamantis T; Kitis G; Kokozidis G; Mallas E; Tjivras M
    J Clin Gastroenterol; 1991 Aug; 13(4):380-3. PubMed ID: 1918842
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparison of the healing capacities of sucralfate and cimetidine in the short-term treatment of duodenal ulcer: a double-blind randomized trial.
    Martin F; Farley A; Gagnon M; Bensemana D
    Gastroenterology; 1982 Mar; 82(3):401-5. PubMed ID: 6895626
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Sucralfate as maintenance treatment for the prevention of duodenal ulcer recurrence.
    Paakkonen M; Aukee S; Janatuinen E; Lahtinen J; Laxen F; Olsen M; Pikkarainen P; Poikolainen E
    Am J Med; 1989 Jun; 86(6A):133-5. PubMed ID: 2660556
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Relapse of gastric ulcers after healing with omeprazole and cimetidine. A double-blind follow-up study. Danish Omeprazole Study Group.
    Scand J Gastroenterol; 1989 Jun; 24(5):557-60. PubMed ID: 2669119
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Mucosa protectives: sucralfate and colloidal bismuth subcitrate in peptic ulcer disease.
    Tytgat GN; Nio CY
    Z Gastroenterol; 1987 Aug; 25 Suppl 3():152-61. PubMed ID: 3660894
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Randomised study of the influence of non-steroidal anti-inflammatory drugs on the treatment of peptic ulcer in patients with rheumatic disease.
    Manniche C; Malchow-Møller A; Andersen JR; Pedersen C; Hansen TM; Jess P; Helleberg L; Rasmussen SN; Tage-Jensen U; Nielsen SE
    Gut; 1987 Feb; 28(2):226-9. PubMed ID: 3549473
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Effectiveness of sucralfate in the treatment of gastric ulcer in women during menopause--comparison with cimetidine].
    Tkaczewski W; Chojnacki J; Grzegorczyk K; Klupińska G; Wichan P; Zabielski G
    Wiad Lek; 1989 Jun; 42(11):717-9. PubMed ID: 2631441
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Treatment of duodenal ulcer with sucralfate.
    Lam SK
    Scand J Gastroenterol Suppl; 1991; 185():22-8. PubMed ID: 1683491
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Are endoscopic and/or histologic findings in gastroduodenal mucosa a predictor of clinical outcome in peptic ulcer disease? A 1-year follow-up study after initial healing with either cimetidine or medium-dose antacid.
    Jönsson KA; Bodemar G; Norrby K; Walan A; Tysk C
    Scand J Gastroenterol; 1988 Mar; 23(2):199-208. PubMed ID: 3283917
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Use of sucralfate in the treatment of peptic ulcer].
    Grigor'ev PIa; Isakov VA; Iakovenko EP
    Klin Med (Mosk); 1989 Jan; 67(1):98-102. PubMed ID: 2716262
    [No Abstract]   [Full Text] [Related]  

  • 51. Short-term treatment with sucralfate or cimetidine in gastric ulcer: preliminary results of a controlled randomized trial.
    Martin F; Farley A; Gagnon M; Poitras P; Bensemana D
    Scand J Gastroenterol Suppl; 1983; 83():37-41. PubMed ID: 6356319
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Treatment of peptic ulcer induced by non-steroidal anti-inflammatory drugs.
    Malchow-Møller A
    Scand J Gastroenterol Suppl; 1987; 127():87-91. PubMed ID: 3303297
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Twice-daily sucralfate dosing to heal acute duodenal ulcer. Multicenter Study Group.
    Schubert T
    Am J Med; 1989 Jun; 86(6A):108-12. PubMed ID: 2660551
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Sucralfate in the treatment and prevention of gastric ulcer: multicentre double blind placebo controlled study.
    Blum AL; Bethge H; Bode JC; Domschke W; Feurle G; Hackenberg K; Hammer B; Hüttemann W; Jung M; Kachel G
    Gut; 1990 Jul; 31(7):825-30. PubMed ID: 2196208
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The other option in peptic ulcer therapy.
    Halter F
    S Afr Med J; 1984 Jun; 65(25):996-1000. PubMed ID: 6374932
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cimetidine, cigarette smoking, and recurrence of duodenal ulcer.
    Sontag S; Graham DY; Belsito A; Weiss J; Farley A; Grunt R; Cohen N; Kinnear D; Davis W; Archambault A
    N Engl J Med; 1984 Sep; 311(11):689-93. PubMed ID: 6382004
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Relapse rate of duodenal ulcer after cessation of long-term cimetidine treatment: a double-blind controlled study.
    Korman MG; Hetzel DJ; Hansky J; Shearman DJ; Don G
    Dig Dis Sci; 1980 Feb; 25(2):88-91. PubMed ID: 6986242
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Antacid/anticholinergic, cimetidine, and placebo in treatment of active peptic ulcers.
    Ström M; Gotthard R; Bodemar G; Walan A
    Scand J Gastroenterol; 1981; 16(5):593-602. PubMed ID: 7034155
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparison of sucralfate with cimetidine in the short-term treatment of chronic peptic ulcers.
    Marks IN; Wright JP; Denyer M; Garisch JA; Lucke W
    S Afr Med J; 1980 Apr; 57(15):567-73. PubMed ID: 6988989
    [No Abstract]   [Full Text] [Related]  

  • 60. Sucralfate in the short-term treatment of duodenal ulcer. A double-blind comparison with cimetidine and placebo.
    Khanna SS; Pipalia DH; Nadkarni PM; Naik SR
    J Assoc Physicians India; 1989 Aug; 37(8):503-5. PubMed ID: 2695513
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.